- Home
- SNSE vs SINT Comparison
SNSE vs SINT Comparison
Compare SNSE & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- SINT
- Stock Information
- Founded
- SNSE 2005
- SINT 1996
- Country
- SNSE United States
- SINT United States
- Employees
- SNSE N/A
- SINT N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- SNSE Health Care
- SINT Health Care
- Exchange
- SNSE Nasdaq
- SINT Nasdaq
- Market Cap
- SNSE 11.2M
- SINT 10.9M
- IPO Year
- SNSE 2021
- SINT 2014
- Fundamental
- Price
- SNSE $11.13
- SINT $4.02
- Analyst Decision
- SNSE Strong Buy
- SINT Strong Buy
- Analyst Count
- SNSE 4
- SINT 1
- Target Price
- SNSE $72.50
- SINT $25.00
- AVG Volume (30 Days)
- SNSE 3.5K
- SINT 123.5K
- Earning Date
- SNSE 11-13-2025
- SINT 11-11-2025
- Dividend Yield
- SNSE N/A
- SINT N/A
- EPS Growth
- SNSE N/A
- SINT N/A
- EPS
- SNSE N/A
- SINT N/A
- Revenue
- SNSE N/A
- SINT $1,861,000.00
- Revenue This Year
- SNSE N/A
- SINT N/A
- Revenue Next Year
- SNSE N/A
- SINT $87.50
- P/E Ratio
- SNSE N/A
- SINT N/A
- Revenue Growth
- SNSE N/A
- SINT N/A
- 52 Week Low
- SNSE $5.00
- SINT $1.71
- 52 Week High
- SNSE $17.40
- SINT $8.60
- Technical
- Relative Strength Index (RSI)
- SNSE 71.14
- SINT 48.92
- Support Level
- SNSE $9.35
- SINT $3.72
- Resistance Level
- SNSE $10.00
- SINT $4.23
- Average True Range (ATR)
- SNSE 0.51
- SINT 0.41
- MACD
- SNSE 0.09
- SINT -0.11
- Stochastic Oscillator
- SNSE 94.27
- SINT 22.67
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.